4.7 Article

Gelation of Covalently Cross-Linked PEG-Heparin Hydrogels

Journal

MACROMOLECULES
Volume 42, Issue 14, Pages 5310-5316

Publisher

AMER CHEMICAL SOC
DOI: 10.1021/ma900766u

Keywords

-

Funding

  1. National Institutes of Health [1 R01 EB003172-01]
  2. National Science Foundation Graduate Research Fellowship
  3. EU Erasmus Mundus and Eurheo programs
  4. National Science Foundation IGERT [DGE-0221651]

Ask authors/readers for more resources

We study PEG-heparin hydrogels to identify compositions that lead to gel formation and measure the corresponding gelation kinetics. The material consists of a maleimide-functionalized high molecular weight heparin (HMWH) backbone covalently cross-linked with bis-thiol poly(ethylene glycol) (PEG). Using multiple particle tracking microrheology, we investigate a broad composition space, defined by then umber of maleimide functional sites per H M WH (f = 3.9-11.8), the molecular weight of the PEG crosslinker (M-n = 2000, 5000, and 10000), and the concentrations of the heparin and PEG polymers. Gelation kinetics are characterized by time-cure superposition, yielding the gel time, t(c), and the critical relaxation exponent, n. Gelation times range from 5 < t(c) <= 45 thin, with the fastest kinetics occurring for the highest H M W H maleimide functionalities. t(c) depends nonmonotonically on the PEG cross-linker molecular weight, suggesting that gelation is affected by the length of the cross-linker relative to intermolecular interactions between heparin molecules. The critical relaxation exponent decreases from n = 0.52 for PEG 2000 to n = 0.39 for PEG 10000. Finally, 219 equilibrated samples taken over the entire composition space are identified as liquid or solid, defining the gelation envelope. The boundaries of this empirical gelation envelope are in good agreement with Flory-Stockmayer theory. In all, micro rheological measurements enable characterization over a large parameter space and provide crucial insight into the gelation of complex, multifunctional hydrogelators used in therapeutic applications.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available